rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ADMA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      ADMA Biologics: Ending 2026 On A High Note (NASDAQ:ADMA)
      Nov 11Seeking AlphaADMA
      ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?
      Nov 11Yahoo FinanceADMA
      Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average
      Nov 6Yahoo FinanceADMA
      Canaccord Genuity Keeps Their Buy Rating on ADMA Biologics (ADMA)

      Tipranks Press Release.

      Nov 6The Globe and MailADMA
      ADMA Biologics CEO Adam Grossman sells $1.76M in shares
      Nov 6Investing.comADMA
      ADMA Biologics stock jumps after Q3 beat (ADMA:NASDAQ)
      Nov 5Seeking AlphaADMA
      ADMA Biologics Inc (ADMA) Q3 2026 Earnings Call Highlights: Asceniv Surge Drives Margin ...

      ADMA Biologics Inc (ADMA) posted 13% sequential revenue growth to $141.1 million with gross margin jumping to 71%, prompting an increase in full-year 2026 adjusted EBITDA and net income guidance.

      Nov 5Yahoo FinanceADMA
      12 Health Care Stocks Moving In Thursday's Intraday Session
      Nov 5BenzingaADMA
      Why Is ADMA Biologics Stock Soaring Thursday? - ADMA Biologics (NASDAQ:ADMA)
      Nov 5BenzingaADMA
      12 Health Care Stocks Moving In Thursday's Pre-Market Session
      Nov 5BenzingaADMA
      Mizuho raises ADMA Biologics stock price target on ASCENIV growth
      Nov 5Investing.comADMA
      ADMA Biologics (ADMA) Shares Jump 28% After-Hours: Here’s Why
      Nov 5BenzingaADMA
      Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates
      Nov 4Yahoo FinanceADMA
      ADMA Biologics Q3 Earnings Call Highlights
      Nov 4Yahoo FinanceADMA
      Adma Biologics: Q3 Earnings Snapshot
      Nov 4Yahoo FinanceADMA
      ADMA Biologics Q3 2026 Earnings Call Transcript
      Nov 4BenzingaADMA
      ADMA Biologics Inc earnings beat by $0.03, revenue topped estimates
      Nov 4Investing.comADMA
      ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
      Nov 4Yahoo FinanceADMA
      ADMA Biologics earnings on deck: Can ASCENIV offset BIVIGAM drag?
      Nov 4Investing.comADMA
      Earnings To Watch: ADMA Biologics Inc (ADMA) Q3 2026 -- GF Value Sees 102% Upside
      Nov 3Yahoo FinanceADMA
      Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
      Oct 30Yahoo FinanceADMA
      Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

      According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

      Oct 29Yahoo FinanceADMA
      Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know
      Oct 29Yahoo FinanceADMA
      ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026
      Oct 28Yahoo FinanceADMA
      Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
      Oct 20Yahoo FinanceADMA
      How Investors May Respond To ADMA Biologics (ADMA) Peer‑Reviewed Validation Of IVIG Safety And Purity
      Oct 15Yahoo FinanceADMA
      ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
      Oct 15Yahoo FinanceADMA
      Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

      In the latest trading session, Adma Biologics (ADMA) closed at $10.33, marking a +1.87% move from the previous day.

      Oct 8Yahoo FinanceADMA
      ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
      Oct 8Yahoo FinanceADMA
      Here's Why Adma Biologics (ADMA) Fell More Than Broader Market

      In the most recent trading session, Adma Biologics (ADMA) closed at $10, indicating a -1.24% shift from the previous trading day.

      Sep 29Yahoo FinanceADMA
      ADMA Biologics (ADMA), Why Is It Back In The Spotlight?

      Recent performance swings in ADMA Biologics (ADMA) have put fresh attention on what investors are paying for its plasma-derived therapies business after a year of sharp declines and a much stronger past 3 months. The recent rebound in ADMA Biologics, with a 12.07% 90‑day share price return, contrasts sharply with a year‑to‑date share price decline of 47.54%, while a very large 5‑year total shareholder return of about 7x signals that long‑term holders have seen substantial gains. Scan beyond...

      Sep 27Yahoo FinanceADMA
      Why Adma Biologics (ADMA) Dipped More Than Broader Market Today

      Adma Biologics (ADMA) closed at $9.52 in the latest trading session, marking a -1.86% move from the prior day.

      Sep 24Yahoo FinanceADMA
      Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
      Sep 24Yahoo FinanceADMA
      Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
      Sep 18Yahoo FinanceADMA
      Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know

      Adma Biologics (ADMA) reached $9.23 at the closing of the latest trading day, reflecting a -1.7% change compared to its last close.

      Sep 11Yahoo FinanceADMA
      Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know

      Adma Biologics (ADMA) closed at $9.36 in the latest trading session, marking a -1.01% move from the prior day.

      Sep 10Yahoo FinanceADMA
      Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?

      Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

      Sep 8Yahoo FinanceADMA
      Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?

      Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Sep 4Yahoo FinanceADMA
      ADMA Biologics: Maybe The Bears Are Right (Rating Downgrade) (NASDAQ:ADMA)

      ADMA Biologics stock is downgraded to Hold as FY26 guidance drops and growth slows. See ADMA's ASCENIV outlook, BIVIGAM decline, and $9.52 DCF.

      Sep 2Seeking AlphaADMA

      This is the newest page. Registered accounts read further back.